![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United States | Publication | February 17, 2022
On February 10, 2022, the US Securities and Exchange Commission (the SEC) proposed rule amendments regarding Schedule 13D and Schedule 13G filings with the intention of providing more timely information to financial markets.
The proposed amendments would:
The proposed amendments would add a new paragraph (e) to Rule 13d-3. Proposed paragraph (e) would deem persons who hold cash-settled derivatives with the purpose or effect of changing or influencing the control of the public company to be beneficial owners. Beneficial owners, for purposes of the proposed new paragraph, would also include those who hold such derivatives in connection with or as a participant in any transaction having such purpose or effect (e.g. transactions designed to pressure the counterparty or the company to make voting or disposition decisions regarding substantial blocks of securities). Security-based swaps, however, are excluded. The proposed amendment takes into consideration the economic power of holders of cash-settled derivatives, who can produce desired outcomes and potentially impact the stock price of a reference security. The rationale behind the amendment is to alert issuers and the market to any large positions in cash-settled derivative securities and, by implication, the possibility of rapid accumulations of, and high concentrations in, the related reference securities.
Lastly, the amendments would require that Schedules 13D and 13G be filed using a structured, machine-readable data language.
The comment period on the proposed amendments will be open until 30 days after the publication in the Federal Register or April 11, 2022, whichever is later. We encourage our clients and other affected investors to provide their feedback to the SEC as soon as possible.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023